CYTOKINETICS INC — Director's Dealing 2014

Feb 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2014-01-31

Reporting Person: CHARPENTIER BONNIE (SVP Regulatory & Compliance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-31	Incentive Stock Option (right to buy)	$7.75	A	28528	Acquired	2024-01-31	Common Stock (28528)	Direct
2014-01-31	Non-Qualified Stock Option (right to buy)	$7.75	A	1472	Acquired	2024-01-31	Common Stock (1472)	Direct

Footnotes

F1: When the ISO and NQ dated 01/31/14 are combined for a total grant of 30,000 shares, the option shall vest and become exercisable as to 7,500 shares on 01/31/15 and the balance of 22,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 01/31/18.